INVESTIGATING THE ROLE OF CELLULAR AUTOPHAGY IN  HUMAN MONOCYTIC CELL DEATH BY KINOME ANALYSIS by Bridge, Rylan
  
 
INVESTIGATING THE ROLE OF CELLULAR AUTOPHAGY IN  
HUMAN MONOCYTIC CELL DEATH BY KINOME ANALYSIS 
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
In Partial Fulfillment of the Requirements 
For the Degree of Master of Science 
In the Vaccinology and Immunotherapeutics Program 
School of Public Health 
University of Saskatchewan 
Saskatoon, Saskatchewan, Canada 
 
By 
 
Rylan Bridge 
 
 
 
 Copyright Rylan Bridge, September, 2016. All rights reserved. 
i 
 
Permission to Use 
 
In presenting this thesis/dissertation in partial fulfillment of the requirements for a Postgraduate 
degree from the University of Saskatchewan, I agree that the Libraries of this University may 
make it freely available for inspection. I further agree that permission for copying of this 
thesis/dissertation in any manner, in whole or in part, for scholarly purposes may be granted by 
the professor or professors who supervised my thesis/dissertation work or, in their absence, by 
the Head of the Department or the Dean of the College in which my thesis work was done. It is 
understood that any copying or publication or use of this thesis/dissertation or parts thereof for 
financial gain shall not be allowed without my written permission. It is also understood that due 
recognition shall be given to me and to the University of Saskatchewan in any scholarly use 
which may be made of any material in my thesis/dissertation. 
 
 
 
Requests for permission to copy or to make other uses of materials in this thesis/dissertation in 
whole or part should be addressed to: 
 Director, Vaccinology and Immunotherapeutics Program 
School of Public Health 
 University of Saskatchewan 
 Saskatoon, Saskatchewan S7N 5E5 
 
  
ii 
 
Abstract 
Cells of the Monocyte / Macrophage lineage are key players in innate and adaptive 
immunity. They eliminate pathogens through their phagocytic and antimicrobial properties, 
secretion of inflammatory and immunoregulatory cytokines, as well as their capacity to present 
foreign antigens to T lymphocytes in lymphoid tissues. The importance of M/Ms in the immune 
response require them to undergo strict regulation, which occurs, at least in part, through the 
control of monocytic cell survival. Autophagy is a ubiquitous cellular process by which cells 
degrade intracellular, cytoplasmic components via a network of interconnected vacuoles to carry 
out a variety of functions. Autophagy typically functions in maintaining cellular homeostasis and 
mitigating stresses. However, more recent studies have shown that autophagy may play a role in 
cell death.  
Our laboratory has previously found that the cytokine IFNγ can induce cell death in human 
monocytes in an autophagy-dependent manner. Conversely, IL-10 inhibits both spontaneous and 
IFNγ-induced cell death, a capacity that ironically, is also associated with the induction of 
autophagy. We are thus interested in understanding how the autophagy pathway can play a dual 
role in human monocyte survival. Interestingly, a novel autophagy-inducing antimicrobial peptide 
(Atg peptide) was recently shown to be capable of inducing an autophagy-dependent form of cell 
death. In this study, I established an in vitro model for Atg peptide-induced cell death in human 
monocytic cells. Subsequently, I designed and tested an autophagy- and cell death pathway-centric 
kinome microarray in order to begin elucidating the molecular mechanisms responsible for 
monocytic cell death. Kinome analysis identified several interesting phosphorylation events in 
response to Atg peptide stimulation, including the tumour suppressor protein p53, which was 
phosphorylated at S9, an Na+,K+-ATPase ATP1A1 which was phosphorylated at Y10, and the 
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transcription factor 4E-BP1 which was phosphorylated at S65. I confirmed these phosphorylation 
results in part using Western blotting. Finally, I present several hypotheses for the potential 
molecular mechanisms involved in Atg peptide-induced autophagic cell death in monocytes 
revealed by kinome analysis, which provide a basis for further exploration into this extremely 
interesting area.
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Chapter 1: General Introduction 
1.1 Autophagy 
1.1.1 Introduction 
Autophagy (a term coined in 1963 by Christian de Duve1, in Greek meaning ‘self-eating’) 
is a complex process by which cells degrade intracellular, cytoplasmic components via a network 
of interconnected vacuoles, termed ‘autophagosomes’ and lysosomes, in order to carry out a 
variety of functions for the cell2. It is important to note the existence of several forms of autophagy, 
including microautophagy (direct engulfment by lytic vacuoles) and chaperone-mediated 
autophagy (a highly-selective form of autophagy), which are present in many cell types3. However, 
the focus of this manuscript is on the prototypical form of autophagy, termed macroautophagy 
(plainly referred to as autophagy henceforth). Autophagy is a ubiquitous and evolutionarily 
conserved process, present in all eukaryotic cells ranging from yeast4, to plants5,6, to modern 
mammals7. Many of the thirty-odd autophagy-regulating genes (termed Atgs) initially discovered 
in yeast have orthologs in other species, and some additional novel autophagy-associated genes in 
higher species have also been identified7. However, despite these minute differences in the 
molecular machinery present in the cell, the cellular autophagy pathway undergoes very similar 
stages in most species: membrane nucleation, membrane elongation, autophagosome maturation 
& closure, autophagosomal fusion with a lysosome generating an autophagolysosome, and 
degradation of vacuolar contents (Fig. 1-1)7. 
 
1.1.2 The autophagic machinery 
 The first step of the autophagy pathway is membrane nucleation or initiation. The source 
of membrane lipids in this step is still debated (as are many aspects of autophagy), with evidence  
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Figure 1-1. The general stages of the autophagy pathway in cells. Membrane nucleation is the 
first step, followed by membrane elongation and enclosure creating the autophagosome. The 
autophagosome then fuses with a hydrolytic enzyme-containing vacuole called a lysosome, 
forming an autophagolysosome. The contents of the autophagolysosome are subsequently 
degraded. Also shown are some early and late stage inhibitors of autophagy, 3-methyladenine and 
chloroquine, and some common protein markers of autophagy, namely p62 and LC3. 
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supporting both de novo generation and ER- as well as other organelle-derived lipid sourcing8,9. 
An ‘isolation membrane’ acts as a scaffold for various proteins that facilitate the elongation of the 
membrane, and eventual autophagosome formation. Key proteins at this stage, depicted in Figure 
1-2, include: 1) the ubiquitin-like conjugating protein systems (one cluster involving ATG5, 
ATG12, and ATG16L and another involving MAP1LC3A (LC3-I) and the phospholipid 
phosphatidylethanolamine), 2) a class III phosphatidylinositol-3-phosphate kinase (also known as 
Vps34/PIK3C3) complex that produces lipid molecules and promotes autophagosome formation10, 
and 3) regulatory kinases unc-51-like kinase (ULK) 1 and ULK29. Several of these proteins, 
especially LC3-II (the lipidated form of LC3-I that is formed during autophagy) and sequestosome-
1 (p62/SQSTM1) are widely used as autophagic markers.  
 
1.1.3 The functions of autophagy 
 1.1.3.1 Maintenance of homeostasis  
 The cellular autophagy process was originally conceived as a mechanism for the regulation 
of homeostasis within the cell1. Basal levels of autophagy (as detected by various methods that 
will be described) can be measured in nearly all cell types. Interestingly, autophagy has been 
implicated as a major player in the cellular integrated stress response11. As such, increases in the 
levels of autophagy can be detected in cells subjected to stresses such as nutrient deprivation, 
growth factor depletion, hypoxia, reactive oxygen species, and others11,12. Nutrient deprivation can 
induce protein catabolism in the form of autophagy to produce amino acids that can then be 
converted into an energy source for the cell by gluconeogenesis13. In the heart, the autophagy 
pathway can play an important role in protecting against ischemic injury through the modulation 
of cell death pathways (described below)14. Reactive oxidative species and other oxidative  
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Figure 1-2. An overview of the key proteins involved in the autophagy cascade. Illustration 
reproduced with modifications courtesy of Cell Signaling Technology, Inc. (www.cellsignal.com). 
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stressors activate various intracellular signalling pathways that can activate autophagy such as 
those involving the mitogen-activated kinase (MAPK) and c-Jun N-terminal kinase 1 (JNK1) 
pathways11. Along the same lines, DNA damage can induce autophagy through the expression of 
the tumor suppressor protein p53 (which coincidentally has both pro- and anti-autophagic 
functions) and its responsive genes11.  
Another way that autophagy regulates cellular homeostasis is, in tandem with the 
proteasomal degradation pathway, through the control of unneeded, extraneous, and misfolded or 
mutated proteins7. Improper clearance of potentially toxic protein aggregates (due to the clearance 
machinery being overwhelmed or lacking the ability to take up such aggregates) can lead to 
numerous pathological states. An example of this function is the role of autophagy in the 
degradation (or lack thereof) of a mutated version of the protein α-synuclein in the brain, which 
has been implicated in the development of Parkinson’s disease (PD) and other neurodegenerative 
disorders termed “α-synucleinopathies”15. Organelles can also be targets of autophagic 
degradation, as evidenced by the autophagy subroutine of selective degradation of defective or 
dysfunctional mitochondria (mitophagy), as a measure to avoid reactive oxygen species 
generation16. The impact of autophagy on cellular homeostasis is critical. However, autophagy 
also performs several other functions that are crucial for the survival of both the cell and the 
organism. 
 
 1.1.3.2 Fighting infection 
 The autophagy machinery is important for the protective functions of certain immune cells, 
a subject that has been extensively reviewed elsewhere3. One such function is the direct elimination 
of pathogens. Autophagy is initiated in response to recognition of pathogen-associated molecular 
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patterns (PAMPs) by certain pattern recognition receptors (PRRs) including toll-like (TLR) and 
nucleotide-binding oligomerization domain-like (NLR) receptors. Subsequent signalling events 
induce uptake of material into double-membraned (xenophagy) or single-membraned (LC3-
associated phagocytosis; LAP) vacuoles, followed by delivery of antimicrobial peptides or the 
activation of the autophagic machinery leading to the degradation of vacuolar contents via fusion 
with a lysosome3. A third category of receptors, sequestosome-like receptors (SLRs), are capable 
of recognizing and targeting harmful cytoplasmic materials and initiating their elimination by 
physical recruitment of the autophagy machinery3. The importance of the autophagy pathway’s 
ability to directly eliminate intracellular microorganisms is critical in phagocytic cells like 
monocytes and macrophages. 
 Another mechanism by which autophagy controls the immune response is through its 
modulation of inflammation. The inflammatory response involves the recruitment of immune cells 
to sites of injury for the purposes of propagation of the immune response and tissue repair17. This 
recruitment process is controlled by various cytokines and other molecules that influence the 
makeup of the inflammatory environment. The inflammasome, a cytoplasmic complex involving 
caspase 1, reacts to PAMPs and damage-associated molecular patterns (DAMPs) by processing 
and releasing pro-inflammatory cytokines such as IL-1β (an inducer of further inflammatory 
molecules like nitric oxide) and IL-18 (which induces Th1 cytokine production and enhances cell-
mediated cytotoxicity)18,19,3. Autophagy can enhance acute inflammatory signalling by enhancing 
the delivery of PAMPs to endosomal TLRs, leading to interferon-α production3. Autophagy may 
also curtail chronic inflammation, as defects in critical autophagy genes are associated with 
inflammatory disorders such as Crohn’s disease3. Conversely, autophagy can suppress 
inflammation by reducing inflammasome activation via clearance of inflammasome agonists using 
7 
 
its degradative machinery. The two-sided nature of this control emphasizes the importance of 
autophagy in inflammation, especially in cells of the innate immune system such as macrophages 
and dendritic cells. 
 One critically important process in the immune response is that of antigen presentation and 
subsequent T cell responses. Briefly, antigen presentation involves the engulfment of either 
intracellular or exogenous antigens, which are then degraded and presented on the surface of 
antigen-presenting cells (APCs), including dendritic cells and macrophages20. These APCs present 
the processed antigens to T cells, which along with costimulatory signals initiate the adaptive 
immune response. Autophagy works in tandem with the cellular proteasome to process proteins 
into peptide antigens for display on major histocompatibility complex (MHC) class II molecules, 
and through LC3-associated phagocytosis may contribute to MHC class I presentation as well3. In 
addition to their ability to influence T cell activation through antigen presentation, autophagy is 
also involved in maintaining T cell homeostasis and function3.  
 
 1.1.3.3 Regulation of cell death 
 Recent studies show that autophagy can play a dual role in cell death, as both an antagonist 
and as an enabler21. However, this area is relatively understudied and some controversy remains22. 
It is clear that autophagy promotes the survival of cells through the mitigation of stress. However, 
under stress, it is possible that autophagy is induced in an attempt to mitigate said stress, and under 
conditions where the cell is unable to do so, it undergoes cell death. It is also possible that in some 
cases the typical machinery required for programmed cell death is insufficient, and the machinery 
for autophagy assists in some way23. Interestingly, the autophagy pathway has recently been 
ascribed a novel form of programmed cell death, which is described in further detail below. 
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1.2 Programmed cell death 
1.2.1 Why do cells die? 
The process of programmed cell death is, similarly to autophagy, a ubiquitously expressed 
and utilized, and tightly regulated, collection of pathways in nearly all cell types24. It may at first 
glance seem counterintuitive for cells to have a mechanism for enacting their own death. However, 
programmed cell death functions as an important mechanism for the control of growth and 
development as well as immunity in eukaryotes. For example, during mammalian growth, the 
nervous system generates an overabundance of cells, followed by the subsequent programmed cell 
death of those cells that do not establish effective synaptic connections24. During infection 
moreover, one of the body’s most important methods for fighting infection is the ability to induce 
the death of infected cells, thus curtailing infection24. Much like autophagy, understanding how 
programmed cell death is regulated in a given disease model may be key to the identification of 
therapeutic targets. Additionally, physical or chemical injury to the cell can bring about cellular 
demise, but in a non-programmed manner25. 
 
1.2.2 Modes of programmed cell death 
Programmed cell death (PCD) is distinguished from a non-programmed cell death, 
historically referred to as necrosis25. PCD often involves the induction of numerous signalling 
pathways in a stepwise manner, whereas necrosis involves almost an immediate cell death, often 
linked to a rapid loss of membrane integrity25. The distinction between programmed and non-
programed is, however, being eroded, with the discovery of a type of programmed necrosis 
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(necroptosis) mediated by receptor-interacting serine-threonine kinases (RIPKs)26. Additionally, 
programmed cell death has been revealed to be broken down into numerous different subroutines, 
utilizing different signalling pathways and effector molecules, and engaging different 
physiological responses, but leading to the same conclusion: cellular demise. The proto-typical 
form of PCD, termed apoptosis, is normally mediated by a cleavage cascade involving a family of 
proteins termed caspases, or cysteine-aspartic proteases24. This type of cell death results in several 
notable phenotypic characterizations, including membrane phosphatidylserine externalization, 
membrane blebbing (while maintaining membrane integrity), and DNA fragmentation24. 
Apoptosis is typically divided into two categories: intrinsic (also known as the mitochondrial 
pathway) and extrinsic (also known as the death receptor pathway), with each being governed by 
a different set of initiating factors and caspases, but both leading to the same end result24. 
 In addition to apoptosis, several other critical subroutines of cell death have been 
elucidated. Pyroptosis, for example, is a type of cell death associated with the inflammatory 
response and mediated by the caspase 1 protein, and is distinct from apoptosis25. In another 
example, cellular detachment of the extracellular matrix can cause anoikis, or cellular “death by 
neglect”27.  
 
1.2.3 Autophagic cell death 
Autophagy was recently attributed to a novel form of cell death, termed autosis22,28. Autosis 
is a highly inducible and reproducible form of cell death that can be down-regulated with the 
knockout of important autophagy-regulatory genes22. Autosis can be induced by a novel 
autophagy-inducing peptide (Atg peptide) comprised of a section of amino acids from the 
autophagy-regulatory protein Beclin 1 and the cellular transducing portion of the Tat protein of 
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human immunodeficiency virus22. Cells undergoing autosis have distinct phenotypic 
characteristics. These include the early presence of autophagosomes followed by their 
disappearance in later stages, focal plasma membrane rupture, convolution and shrinkage of the 
nuclear membrane, ballooning of the perinuclear space, concavity of the nuclear surface, and 
abnormal mitochondria and ER22. Interestingly, a screen of potential autosis inhibitors implicated 
molecules referred to as cardiac glycosides, which inhibit the activity of cellular sodium-potassium 
ATPases28. This suggested the involvement of Na+,K+-ATPases in the mechanism of autosis.  
It is unclear to date what role autosis may play in numerous autophagy- and cell-death-
implicated pathologies. Several important diseases, including cancers, neurodegenerative 
disorders, and infectious and autoimmune disorders have been linked to the dysregulation of 
autophagy and programmed cell death29. This underlines the importance of tight regulation of both 
autophagy and programmed cell death, and the interaction between these processes.  
Despite its ability to induce autosis in cells at relatively high concentrations, the autophagy-
inducing peptide may have several potential therapeutic applications either by the induction of 
autophagy or cell death by autosis. For example, the peptide displayed an ability to reduce titres 
of certain positive-stranded RNA viruses both in vitro as well as in vivo30.  
 
1.3 Monocytes and macrophages 
1.3.1 Importance in immunity 
Monocytes and macrophages (M/Ms) represent a key segment of the innate immune 
system, which is the early, non-antigen-specific response to pathological agents31,32. The innate 
immune response is generally initiated via the recognition of the previously-described PAMPs, 
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motifs that are commonly conserved on pathogens and not found in higher eukaryotes. PAMPs are 
recognized by PRR expressed by innate immune cells including dendritic cells, M/Ms, and 
neutrophils31,33. Recognition of PAMPs by PRRs such as TLRs signals for the recruitment of 
adaptor molecules like MyD88, leading to the subsequent activation of transcription factors like 
NF-κB, which are responsible for inducing the expression of pro-inflammatory cytokines and the 
activation of inflammasomes31. This cellular response ensures that the milieu at the site of the 
infection or wound is ideal for the recruitment of immune cells to drive the immune response as 
well as tissue repair. In addition to cytokine secretion and immune response mobilization, M/Ms 
are involved in the direct degradation of harmful agents via phagocytosis, which as previously 
described involves vacuolization of harmful materials followed by recruitment of the autophagy 
machinery and lysosomal fusion3. 
 M/Ms are also critical in the control of infection by mobilizing the adaptive immune 
system, the anemnestic and antigen-specific immune response. APCs such as dendritic cells and 
in some cases macrophages recognize PAMPs through their PRRs as previously described. 
Extracellular pathogenic proteins are degraded and processed into peptide antigens, which are 
presented on MHC class II molecules on the cell surface20. Following migration to the lymph nodes 
and the display of peptide antigens in conjunction with MHC class II and other co-stimulatory 
signals on the DC surface, the cells communicate with and activate CD4+ T helper cells, which 
produce “helper” cytokines that drive the adaptive immune response. Similarly, MHC class I 
molecules display mainly endogenously processed antigens, including self- and pathogen-specific 
peptide antigens, on all non-nucleated cells. These can then be probed and foreign antigens are 
targeted by CD8+ cytotoxic T cells, leading to the elimination of the infected cell34. 
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1.3.2 Regulation of M/Ms function 
Due to their importance in both the innate and adaptive arms of the immune system, tight 
regulation of M/M function is critical for the host to eliminate and survive infection. Furthermore, 
the failure to control and downregulate an immune response once infection is cleared can be just 
as damaging as an inadequate immune response to the invading pathogen. Several mechanisms 
exist to control both the up- and down-regulation of M/M functions. Monocytes are the precursors 
for most phenotypes of macrophages, and differentiate into macrophages in the tissues in response 
to the signals at the damaged site35. Due to the potential differences in macrophage function 
following differentiation, a paradigm has been proposed to describe the different avenues of 
macrophage activation, termed classic (M1) and alternative (M2)36. Classic activation of 
macrophages occurs in response to stimulation with IFNγ, lipopolysaccharides, virus particles or 
granulocyte macrophage colony-stimulating factor (GM-CSF), and occurs as a precursor to proto-
typical Th1 immune responses, including inflammation and the killing of intracellular pathogens36. 
Alternative activation is stimulated by IL-4, IgG, IL-10, and macrophage colony-stimulating factor 
(M-CSF), and can be subdivided into three subtypes: M2a, facilitating allergy and parasitic 
immune responses, M2b, facilitating immunoregulation via crosstalk with B cells, and M2c, 
facilitating tissue remodelling and repair36. While this paradigm is useful in classifying different 
types of macrophage activation in response to differing types of disease, the in vivo make up of 
activated macrophages is likely fluid and thus should not be constrained too narrowly.  
In addition to the regulation of M/Ms by cytokines, other compounds can also affect the 
potency of M/Ms. For example, inducing autophagy in M/Ms using the pharmaceutical drug 
rapamycin can often stimulate their anti-microbial potential, leading to faster clearance of 
infection37. However, this type of M/M regulation can also be hijacked by pathogens. For example, 
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the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) may exploit the autophagy 
pathway to enhance its replication38.  
 
1.4 Cellular signalling by protein phosphorylation 
Cellular signalling by protein phosphorylation is one of the major forms of signalling 
carried out by all types of cells, and is separate from other forms such as ubiquitination or ion 
binding. In eukaryotes, the large majority of phosphorylation events occur on the hydroxyl-
containing amino acids: serine, threonine, and tyrosine39. These amino acid residues act as a 
substrate for protein kinases, which reversibly attach a phosphate group, sourced from ATP, to the 
free hydroxyl of the amino acid39. Binding of the phosphate group can induce a number of protein 
changes, often in protein conformation and/or protein polarity, and modulate protein-protein 
interactions to propagate intracellular signalling. Attached phosphate groups can also be removed, 
by protein phosphatases, to downregulate the effect39. Thus, both protein phosphorylation and 
dephosphorylation are critical events in cellular signalling. Individual phosphorylation events are 
often part of a larger phosphorylation cascade, in which an initial signal can be transduced through 
multiple signalling proteins via subsequent phosphorylation events39. These types of signalling 
cascades, due to their importance in cell survival, are tightly controlled and highly complex, and 
our understanding of many of these pathways is incomplete. 
Kinome microarray analysis represents a large step forward in our approach to better 
understand cellular signalling events in a high-throughput manner, in silico (Fig. 1-3)40. Following 
the principle used for genetic microarrays, kinome microarrays include numerous peptides 
attached to a solid support in a grid-like format. These peptides represent the phosphorylation 
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Figure 1-3. A general overview of the kinome microarray design and analysis protocol. A list 
of proteins of interest is gathered and key protein phosphorylations are assembled from the 
literature via the database phosphosite.org41. The 15 amino acid sequences (seven amino acids on 
each side of the phosphorylated residue) are generated and attached to a solid support. Cell lysates 
are generated and incubated on the microarray along with an activation mix containing ATP. 
Arrays are then incubated with a phospho-protein stain and fluorescence is detected, followed by 
analysis of the identity of phosphorylated peptides and signal intensity. 
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sites of proteins of interest, usually a 15 amino acid sequence in which the eighth amino acid is 
the phosphorylated residue. The peptides can be chosen to represent a broad array of signalling 
proteins for use as a screening tool or be more fine-tuned to specific pathways, and are used to 
detect the phosphorylation cascades that occur in response to a given cell stimulus. Arrays are 
incubated with stimulated cell lysates that contain cellular kinases, proteins that phosphorylate 
other proteins. These kinases phosphorylate the peptides on the microarray, which are then 
detected using a phospho-stain and analyzed. On the whole, kinome arrays thus allow 
experimenters to examine the signalling capacity of the cell in response to different treatments. 
This technology, despite its novelty, has already been advanced in several ways since its 
inception. It can be expanded to species that do not have commonly available phosphorylation data 
via prediction of conserved peptide sequences42,43,44. Additionally, specifically-tailored tools for 
analyzing kinome data have been developed45. We thus opted to use kinome microarray analysis 
to enhance our understanding of the molecular mechanisms of monocyte cell death. 
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Chapter 2: Thesis Rationale and Objectives 
In addition to the M1-defining, anti-microbial inductive capacity of IFNγ, this important 
cytokine also plays other roles. We have previously found that IFNγ stimulation of monocytes also 
induced death in these cells, which may function as a regulatory mechanism in controlling the 
immune response (Fig. 2-1A)46. In contrast, monocytes stimulated with IL-10, an M2-defining and 
immunoregulatory cytokine, curtails both spontaneous and IFNγ-induced cell death (Fig. 2-1A)47. 
Furthermore, we found that spontaneous and IFNγ-induced cell death was caspase-independent, 
but rather involved the autophagy pathway and could be reduced by inhibiting autophagy (Fig. 2-
1B)47. Interestingly, the pro-survival effects of IL-10 were also associated with the autophagy 
pathway47. Therefore, our laboratory is interested in understanding the molecular mechanisms 
responsible for the dual role of autophagy in monocytic cell death. We are also investigating the 
anti-microbial capacity of the Atg peptide mentioned above, a peptide that has been shown recently 
to induce autophagic cell death28. As a result, I aimed to develop and evaluate a kinome array 
approach for the further study of monocyte autophagic cell death with the following specific 
objectives. 
1. Establish an in vitro model to study the regulation of programmed cell death in monocytic 
cells 
2. Design and test a kinome-based approach to investigate the molecular mechanisms 
associated with autophagic cell death in monocytic cells  
i. Designing the kinome array 
ii. Analyzing the array data 
3. Validate kinome array results by Western blotting 
17 
 
 
 
 
 
 
Figure 2-1. Relative cell death of monocytes in response to IFNγ and IL-10 treatment. Flow 
cytometric analysis of cell death in human monocytes A) stimulated with 10 ng/mL IFNγ and/or 
IL-10, and B) in monocytes pre-treated with the autophagy inhibitors Chloroquine (Chq; average 
of 6.25 to 25 µM) and 3-methyladenine (3-MA; average of 5 to 10 µM) followed by stimulation 
with 10 ng/mL IFNγ47. 
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Chapter 3: Materials and Methods 
3.1 Isolation of monocytes from human peripheral blood mononuclear cells  
 Following University of Saskatchewan Ethics Board approval, between 200 and 250 mL 
of blood were collected from each volunteer blood donor by peripheral venipuncture (TLC Mobile 
Lab, Saskatoon, SK, CA). Blood was mixed with an equal volume of sterile phosphate-buffered 
saline (PBS; Sigma-Aldrich, St. Louis, MI, USA), and approximately 37 mL of this mixture was 
layered over 12 mL of Ficoll-Paque Plus (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA). The 
layered blood was centrifuged at 400 x g for 45 minutes without applying centrifuge brake. The 
resulting buffy coat containing peripheral blood mononuclear cells (PBMCs) was extracted and 
washed twice in sterile PBS. PBMCs were counted and monocytes were isolated by either positive 
or negative selection using Miltenyi Biotec CD14 Microbeads or the Pan Monocyte Isolation Kit, 
respectively, as recommended by the manufacturer (Miltenyi Biotec, Auburn, CA, USA). Briefly, 
for positive selection, PBMCs were resuspended in magnetic activated cell sorting (MACS) buffer 
supplied by the manufacturer, and 20 µL anti-CD14-conjugated microbeads were added per 107 
cells. The mixture was incubated in the dark at 4 °C for 15 minutes. To wet the separating column, 
3 mL of MACS buffer were added. Cells were washed in MACS buffer, then centrifuged at 300 x 
g for 10 minutes, and then resuspended in a final volume of 500 µL of MACs buffer. The 
suspension was added to the column with the magnet applied, and the flow-through fraction was 
discarded. With the magnet still applied, the column was washed three times with MACS buffer. 
Finally, the column was removed from the magnet and 5 mL of MACS buffer was added. The 
plunger was used to push the remaining monocyte-enriched cell fractions into a fresh tube. Cells 
were then counted and subsequently cultured. 
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For negative selection, PBMCs were resuspended in MACS buffer, and 10 µL FcR 
Blocking Reagent and 10 µL Biotin-Antibody Cocktail were added per 107 cells. The mixture was 
incubated in the dark at 4 °C for 5 minutes. 30 µL of MACS buffer was then added, followed by 
20 µL of Anti-Biotin Microbeads per 107 cells and subsequent incubation in the dark at 4 °C for 
10 minutes. The separating column was pre-wet with 3 mL of MACS buffer. Cells were 
resuspended in a volume of 500 µL of MACS buffer, and with the magnet applied the suspension 
was added to the column. The flow-through, containing the monocyte-enriched fraction, was 
collected and the column, with the magnet still applied, was washed three times with MACS buffer 
and combined with the previous flow-through. Cells were then counted and subsequently cultured. 
 
3.2 Culture of human monocytes and the U937 monocytic cell line 
 After isolation, human monocytes or U937 monocytic cells (American Type Culture 
Collection, Manassas, VA, USA) were cultured in RPMI 1640 (GE Healthcare) supplemented with 
10% fetal bovine serum (FBS; GE Healthcare), 1% sodium pyruvate, 1% β-mercaptoethanol 
(Sigma-Aldrich), and 10 U/mL Penicillin-Streptomycin (PenStrep; Life Technologies, Carlsbad, 
CA, USA). Cells were incubated to 1 x 106 cells/mL at 37 °C and 5% CO2.  
 
3.3 Flow cytometric analysis of purity of monocyte cultures 
 After isolation, human monocytes were fixed in 2% paraformaldehyde for 10 minutes at 4 
°C. The cells were then washed in 0.1% bovine serum albumin (BSA; Sigma-Aldrich)/PBS 
containing buffer, followed by resuspension at a final volume of 100 µL. 20 µL of mouse anti-
human CD14+-PE or mouse IgG1-PE isotype control (ThermoFisher Scientific, Waltham, MA, 
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USA) antibodies (Abs) were added and incubated for 15 minutes at room temperature. Cells were 
washed once more in 0.1% BSA/PBS buffer, then resuspended in 2% paraformaldehyde until 
analysis. Samples were analyzed using a BD FACSCalibur flow cytometer (BD Biosciences, San 
Jose, CA, USA) and the FlowJo analysis software (FlowJo, LLC, Ashland, OR, USA). 
 
3.4 Cell stimulations 
 For the quantification of cell death, 5 x 105 U937 monocytic cells or isolated primary 
human monocytes were rested in fresh media for 1 hr. This was followed by cell stimulation with 
5, 15, and 30 µM (for U937 cells) or 2.5 µM (for primary monocytes) of autophagic cell death-
inducing peptide (Atg peptide), or 30 µM of a scrambled sequence (Control) peptide (both Atg 
peptide and Control peptide kindly provided by Dr. Beth Levine, Howard Hughes Medical Center, 
University of Texas Southwestern) or cells were left untreated overnight at 37 °C and 5% CO2. 1 
µM staurosporine (Sigma-Aldrich) stimulation overnight was used as a positive control for cell 
death48.  
For the kinome analysis, 25 x 106 U937 monocytic cells were rested in fresh media for 1 
hr, followed by stimulation with 30 µM of Atg peptide, Control peptide or left untreated for 15 
min or 1 hr at 37 °C and 5% CO2. Two replicate experiments were performed. 
For Western blots, 4 x 106 U937 monocytic cells were rested in fresh media for 1 hr, 
followed by stimulation with 30 µM of Atg peptide, Control peptide or left untreated for 15 min 
or 1 hr at 37 °C and 5% CO2. 
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3.5 Quantification of cell death by flow cytometry 
 Cell death following the various stimulations was quantified using the Alexa Fluor® 488 
Annexin V/Dead Cell Apoptosis Kit (ThermoFisher Scientific) according to the manufacturer’s 
instructions. Briefly, 5 x 105 cells were washed twice in PBS, followed by resuspension in 100 µL 
of annexin binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4). 5 µL of 
Annexin V-488 conjugate and 1 µL of 100 µg/ml propidium iodide (PI) were added, followed by 
a 15 min incubation period at room temperature. 400 µL of annexin binding buffer were added 
and cells were kept on ice until detection on a flow cytometer. Dead cells were quantified by 
calculating the percentage of Annexin V-488+/PI+ cells. Samples were analyzed using a BD 
FACSCalibur flow cytometer and FlowJo analysis software. 
 
3.6 Cellular protein extraction and quantification 
 Cell pellets of 4 x 106 or 10 x 106 cells were kept on ice and washed once in PBS, followed 
by resuspension in protein extraction buffer (10 mM Tris, pH 8, 50 mM NaCl, 2 mM EDTA, 1 
mM EGTA, 1% Triton X-100, 50 mM NaF, 1 mM Na3VO4, 1 mM PMSF, 1X cOmplete Mini 
Protease Inhibitor Cocktail TabletTM (Roche Life Science, Laval, QC, CA) for Western blotting or 
kinome extraction buffer (20 mM Tris, pH 8, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% 
Triton X-100 (Sigma-Aldrich), 2.5 mM sodium pyrophosphate, 1 mM Na3VO4, 1mM NaF, 1 mM 
PMSF, 1 µg/mL aprotinin (Sigma-Aldrich), 1 µg/mL leupeptin (Sigma-Aldrich)) for kinome 
analysis. This suspension was centrifuged at 20 000 x g for 20 minutes and the protein-containing 
supernatant transferred to a separate tube. Proteins were quantified with the Bradford method49 
using a Bio-Rad Protein Quantification Kit (Bio-Rad, Hercules, CA, USA). Briefly, working dye 
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reagent was prepared by adding 4 parts ddH2O to 1 part stock dye concentrate. Proteins were 
diluted 1:10 in ddH2O and 10 µL diluted protein added to 200 µL working dye reagent. The 
solution was incubated at room temperature for 5 minutes and then analyzed using a 
spectrophotometer at 595 nm. Sample protein concentrations were interpolated from a standard 
curve generated using serial dilutions of a known quantity of BSA protein. 
 
3.7 Western blotting 
 Polyacrylamide gels were prepared (Resolving gel: 14% bis-acrylamide (Sigma-Aldrich), 
0.39 mM Tris pH 7.4, 0.1% (w/v) sodium dodecyl sulphate (SDS), 1 µg/ml ammonium persulphate 
(APS), and 0.1% (v/v) tetramethylethylenediamine (TEMED); Stacking gel: 6.5% bis-acrylamide, 
0.14M Tris-HCL pH 6.8, 0.11% (w/v) SDS, 1 µg/ml APS, 0.11% (v/v) TEMED) and 60 µg protein 
samples were loaded. Gels were electrophoresed at 150 V for 2 hours, or until the dye front 
migrated out of the gel. Proteins were wet transferred onto polyvinylidene fluoride (PVDF; 
ThermoFisher Scientific) membranes at 300 mA for 1 hour. Membranes were blocked in 5% 
BSA/PBS for LC3-II and p62 expression or 5% BSA/Tris Buffered Saline (TBS) for 
phosphoprotein expression overnight at 4 °C or for 1 hour at room temperature, respectively. 
Membranes were washed three times in PBS-0.1% Tween (PBST) and probed for LC3 and p62 
expression or TBS-0.1% Tween (TBST) for phosphoprotein expression and then incubated with 
primary antibody (anti-p62 at 1:1000; anti-GAPDH at 1:2000; anti-β-actin at 1:2000; anti-
Phospho(Ser136)-Bad at 1:500; anti-Bad at 1:500; anti-Phospho(Ser9)-p53 at 1:500; anti-p53 at 
1:500; anti-Phospho(Y10)-ATP1A1 at 1:500; antanci-ATP1A1 at 1:500; anti-Phospho(Ser65)-4E-
BP1 at 1:500; anti-4E-BP1 at 1:500 (Cell Signaling Technologies, Danvers, MA, USA)) in the 
appropriate blocking solution for 90 minutes at room temperature or overnight at 4°C. This was 
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followed by three more washes in PBST and subsequent incubation with secondary antibody (anti-
Rabbit Cy5; anti-Rabbit Cy3; anti-Mouse Cy3 (Cell Signalling Technologies)) at a dilution of 
1:2500 in PBST or TBST for 1 hour. Finally, the membrane was washed three times in PBST or 
TBST and three times in PBS or TBS, and allowed to dry overnight in the absence of light. 
Membranes were imaged using a Bio-Rad VersaDoc. Western blot images and detected band 
intensities were analyzed using the Bio-Rad Image Lab Software. Band intensity values were 
extracted into Microsoft Excel and protein of interest intensities were compared to housekeeping 
protein intensities to generate a ratio of protein expression. 
 
3.8 Kinome analysis 
3.8.1 Kinome array design & production 
To design the kinome array, proteins involved in the autophagic machinery, typical 
apoptotic proteins, alternative forms of cell death like necroptosis, as well as key upstream 
signalling molecules, were chosen via a thorough search and review of the literature (Fig. 3-1). 
From this generated list of key proteins, their respective phosphorylation sites were identified 
based on the presence of records from the literature referenced on the phosphosite.org website41. 
Identified sites were chosen based on the use of site-specific experimental methods to establish 
protein function, and relevance of the function to autophagy and/or cell death. The chosen 
phosphorylation site 15 amino acid sequences (7 amino acids on either side of the phosphorylated 
residue) were recorded. In total, 298 unique peptide sequences were chosen (Table 3-1), and sent 
to JPT Peptide Technologies (Berlin, Germany) for synthesis and array production. Each array 
contained 3 technical replicates per selected peptide. 
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Figure 3-1. A sampling of proteins and signalling pathways represented on our custom 
kinome array. 
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Table 3-1. A list of the proteins and their associated phosphorylation sites represented 
on the autophagy- and cell-death-specific kinome array  
26 
 
Table 3-1, continued. 
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3.8.2 Kinome analysis protocol 
Kinome analysis was performed as previously described with some modifications42. Two 
biological replicates per treatment were used. Briefly, 10 x 106 cells were lysed in 100 µL of 
Kinome Lysis Buffer (1µg/mL Aprotinin, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 1 mM NaF, 
1 mM Na3VO4, 1µg/mL Leupeptin, 1 mM PMSF, 20 mM Tris-HCl pH 7.5, 1% Triton, 2.5 mM 
sodium pyrophosphate) and incubated on ice for 10 minutes, followed by centrifugation at 14000 
x g at 4 °C for 10 minutes. 70 µL of cellular lysate was mixed with 10 µL of Activation Mix (500 
µM ATP, 0.05% v/v Brij-35, 0.25 mg/ml BSA, 50 mM MgCl2, 50% glycerol) and incubated on a 
microarray for 2 hours at 37 °C. The microarray was then washed and incubated in ProQ Diamond 
Phosphoprotein Stain (ThermoFisher Scientific) with agitation for 1 hour, followed by three 
destaining washes (20% acetonitrile, 50 mM sodium acetate at pH 4.0) and a final wash in distilled 
H2O. The arrays were allowed to dry and scanned at 532 to 560 nm using a GENEPIX 4200A 
microarray scanner (Molecular Devices, Sunnyvale, CA, USA), and analyzed using the GENEPIX 
6.0 software.  
Relative phosphorylation of peptides was calculated using PIIKA software45. Briefly, raw 
intensity data was extracted from GENEPIX 6.0 in Microsoft Excel. Raw intensities were 
organized according to PIIKA specifications and entered into PIIKA45. Treatment-treatment 
variability analysis using t tests provided differentially phosphorylated peptides, which were then 
filtered and visualized by significance and fold-change (FC). 
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Chapter 4: Results 
4.1 Objective 1: Establish an in vitro model to study the regulation of programmed cell 
death in monocytic cells 
4.1.1 Purity of peripheral blood mononuclear cells and isolated human monocytes 
Our laboratory is interested in elucidating the molecular mechanisms responsible for 
programmed cell death in human monocytes. Therefore, my first objective was to establish an in 
vitro model to enable the further study of monocytic cell death. Primary human monocytes were 
isolated from the peripheral blood of human volunteers by positive and negative selection 
techniques. The purity of monocyte isolations was subsequently evaluated by staining with anti-
CD14 antibodies (Abs) and flow cytometric analysis. Positive selection returned over 90% 
monocyte purity and negative selection returned approximately 70% purity (Fig. 4-1). Due to this 
higher purity, positive selection of monocytes was used for all subsequent experiments involving 
primary cells. 
 
4.1.2 Autophagic cell death in primary human monocytes 
 As mentioned above, previous studies in the laboratory have found contrasting effects on 
monocytic cell death by the cytokines IFNγ and IL-1047. IFNγ is capable of inducing cell death in 
monocytes, while IL-10 exerts a protective effect against both IFNγ-induced and spontaneous 
monocytic cell death. Interestingly, both of these effects were found to be caspase-independent, 
and instead involved the autophagy pathway. Interesting also was the observation of the effects of 
the Atg peptide, capable of inducing autophagic cell death in numerous models30. Therefore, I 
evaluated the capacity of the Atg peptide to induce autophagic cell death in primary human 
monocytes (Figure 4-2A). Monocyte cell death was found to occur in response to a 2.5 µM  
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Figure 4-1. Flow cytometry analysis of human monocytes isolated from peripheral blood 
mononuclear cells using either positive or negative selection. CD14+ antibodies were used to 
detect the monocyte population, mouse IgG1 was used as a negative control. 
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Figure 4-2. Relative cell death of monocytes or monocytic cells in response to Atg peptide 
treatment. Primary human monocytes (A) or U937 cells (B) were stimulated overnight with an 
autophagic cell death-inducing peptide (Atg peptide). 1 µM Staurosporine (Stauro) was used as a 
positive control for cell death. A scrambled peptide sequence (Control; 30 µM) was used as a 
negative control. Cells were then collected, stained with propidium iodide and analyzed using flow 
cytometry to detect programmed cell death. Cell death is shown as % relative to the sample 
exhibiting the highest induction (Relative Cell Death), ie. Staurosporine in (A) and 30 uM Atg 
Peptide in (B). One representative experiment each among greater than three conducted. 
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concentration of Atg peptide, roughly doubling the relative cell death of untreated cells and nearing 
the levels observed for the potent inducer of cell death Staurosporine48, used as a positive control. 
 
4.1.3 Autophagic cell death in a monocytic model cell line 
 In addition to primary monocytes, the U937 cell line is commonly used as an in vitro model 
human monocytic cell system. Therefore, I evaluated the effect of the Atg peptide on cell death in 
U937 cells (Figure 4-2B). The level of autophagic cell death detected rose with increasing 
concentrations of the Atg peptide from 5 to 30 µM, even exceeding those found in the positive 
control Staurosporine at the highest concentration. In contrast, cell death was not appreciably 
increased at the highest concentration (30 µM) of Control peptide. 
 
4.2 Objective 2: Design and test a kinome-based approach to investigate the molecular 
mechanisms associated with autophagic cell death in monocytic cells 
Having found that the Atg peptide potently induced cell death in both primary monocytes 
and the U937 monocytic cell line, the focus of my project turned to the design of a kinome 
microarray approach to study this phenomenon in greater detail. Kinome analysis would allow the 
identification of the potential signalling events that may be responsible for Atg peptide-induced 
autophagic cell death. It would also provide our laboratory with a powerful new tool to further 
investigate the dual role of the autophagy pathway in controlling cell death or survival, an example 
being the opposing death versus survival effects associated with IFNγ and IL-10, respectively, in 
monocytes. Thus, I proceeded to design a custom, autophagy-centric array, as described in section 
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3.8.1 above. Subsequently, the kinome array was synthesized and evaluated in the Atg peptide-
treated monocytic cell model. 
 
4.2.2 Kinome analysis of Atg-peptide stimulated monocytic cells 
Due to the high number of cells required to attain sufficient protein concentrations for 
kinome analysis, as well as their relative ease of manipulation, I elected to use the U937 monocytic 
cell line rather than primary monocytes to initially evaluate our autophagy kinome arrays. U937 
cells were treated with 30 µM Atg peptide or Control peptide or left untreated for 15 minutes and 
1 hour. These time points were selected as a starting point, to detect both early and more distal 
signalling events in response to Atg peptide stimulation using this approach.  
Overall, as depicted pictorially in Figures 4-3 and 4-4 by a visualization scheme and 
hierarchical clustering, respectively, the results show substantial phosphorylation differences 
between treatments for both 15 min and 1 hr. In Figure 4-3, data for peptides exhibiting similar 
levels of phosphorylation in response to Atg peptide versus control peptide are represented as 
symbols with homogeneous colouring. Peptides represented on the array that were differentially 
phosphorylated are depicted with symbols of heterogeneous colours, with yellow indicating 
increased phosphorylation compared to untreated control cells, and blue colouring indicating 
decreased phosphorylation. The relative degree of (de)phosphorylation corresponds with the 
intensity of the colour. Figure 4-4 demonstrates the hierarchical clustering of peptide 
phosphorylation status in response to treatments. Again, it appears that on the whole, the Atg 
peptide alters phosphorylation status appreciably more than control peptide, as compared to 
untreated samples. This is reflected by the relative distances between treatments in the upper 
dendrogram (Fig. 4-4A). Additionally, peptides with significant differential phosphorylation  
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Figure 4-3. Differential phosphorylation of individual peptides revealed by kinome analysis. 
Results are given at 15 minutes (A) and 1 hour (B). Each spot represents a peptide. The left half 
represents phosphorylation in response to Atg peptide treatment, and the right half represents 
phosphorylation in response to Control peptide treatment. Yellow colouring indicates an increase 
in phosphorylation, compared to untreated samples, while blue colouring indicates a decrease in 
phosphorylation, compared to untreated samples. Blank spots indicate inconsistent spot 
identification by chi-squared testing. 
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Figure 4-4. A dendrogram and heatmap of the hierarchical clustering of peptide 
phosphorylation status. Results are shown between untreated, Control and Atg peptide treated 
samples at 15 minutes and 1 hour.  
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(p<0.05; FC>1.5 or FC<-1.5) between treatments (Atg peptide-treated and Control peptide-treated, 
both with Untreated signal background subtracted) are listed in Table 4-1. Several of the interesting 
results were selected for further analysis and validation of the approach (Table 4-2). From these 
results, several potential hypotheses regarding the mechanism of autophagy-inducing peptide cell 
death are discussed. 
 
4.3 Objective 3: Validation of kinome array results by western blotting 
Due to the nature and relative novelty of the kinome array technique and the associated 
results obtained, it was important to confirm our findings by Western blotting, a more conventional 
approach to analyzing protein phosphorylation cascades. The proteins described in Table 4-2 were 
evaluated in U937 cells stimulated with Atg peptide by Western blotting in an attempt to confirm 
kinome results. 
 
4.3.1 p53 phosphorylation at S9 is induced by Atg peptide stimulation 
U937 cells were stimulated with 30 µM Atg peptide for 15 min and 1 hr, similar to what 
was done for kinome analysis. Phosphorylation of p53 at residue S9 was found to be clearly 
upregulated in response to Atg peptide stimulation relative to untreated or control peptide-
stimulated cells (Fig. 4-5). This observation was in line with findings of the kinome microarray 
experiments, which showed increased levels of S9 p53 phosphorylation at 15 minutes and 1 hour. 
Attempts were made to probe membranes with a total p53 antibody, but the signal was weak and 
inconsistent, and therefore not pursued further. 
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Table 4-1. Results from kinome analysis, detailing peptides whose phosphorylation was 
significantly altered in response to Atg peptide vs Control peptide treatments 
 
Significant difference in phosphorylation was defined as results with p<0.05, and a FC>1.5 or 
FC<-1.5. Bolded peptides were selected for further analysis and validation experiments. 
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Table 4-2. Differentially phosphorylated peptides chosen for further analysis  
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Figure 4-5. Western blot analysis of p53 protein phosphorylation at residue S9. U937 cells 
were treated with Atg peptide, Control peptide, or left untreated for 15 min and 1 hr. Bands of A) 
phospho-p53 were compared against B) β-actin expression. Antibodies directed against total p53 
protein yielded a very weak and inconsistent signal that could not be used in further analysis (not 
shown.) Similar trends were observed in three separate experiments. 
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4.3.2 4E-BP1 phosphorylation at S65 
Determining the phosphorylation status of 4E-BP1 was significantly more challenging than 
p53. There appeared to be little appreciable difference in the phosphorylated form of 4E-BP1 
between treatments (Fig. 4-6A). Furthermore, the antibody directed against total 4E-BP1 revealed 
a few different species (Fig. 4-6B), making it difficult to distinguish the corresponding 
phosphorylated form detected using the phospho-4E-BP1-specific antibody. Of note also, β-actin 
expression was observed to be appreciably reduced in Atg peptide-treated cells (Fig. 4-6C). We 
attempted to use an alternative control protein, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), but found similar results (not shown.) Therefore, Western blotting results need to be 
interpreted with caution. Indeed, when compared to β-actin expression, quantification of the bands 
detected for Phospho-4E-BP1 suggested an increase in S65 phosphorylation at both 15 minutes 
and 1 hour (Fig. 4-6D). However, when signal intensities were normalized against the total signal 
detected for the multiple species of 4E-BP1, the effect was reversed at 15 minutes or negligible at 
1 hour between the Control and Atg peptide treatments (Fig. 4-6E). Kinome microarray results, on 
the other hand, suggested an increase in phosphorylation at 15 minutes but a decrease at 1 hour. 
 
4.3.3 ATP1A1 phosphorylation at Y10 
 Y10-phosphorylation of ATP1A1 was also examined. Phosphorylated ATP1A1 appears to 
increase slightly in Atg-peptide treated samples, particularly at 1 hour post-stimulation (Fig. 4-
7A). Interestingly, total ATP1A1 expression appears to increase concordantly (Fig. 4-7B). Similar 
quantification of the band intensities and comparison to β-actin levels indicated an increase in 
Y10-phosphorylation in response to Atg peptide stimulation (Fig. 4-7D). Normalization of the 
signals to total ATP1A1 expression showed a similar trend when comparing Atg peptide to Control  
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Figure 4-6. Western blot analysis of 4E-BP1 protein phosphorylation at residue S65. U937 
cells were treated with Atg peptide, Control peptide, or left untreated for 15 min and 1 hr. Similar 
trends were observed with three different experiments. 
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Figure 4-7. Western blot analysis of ATP1A1 protein phosphorylation at residue Y10. U937 
cells were treated with Atg peptide, Control peptide, or left untreated for 15 min and 1 hr. Similar 
trends were observed in three separate experiments. 
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peptide (Fig. 4-7E). The kinome array results showed decreased levels of phosphorylation at 15 
minutes, but increased levels at 1 hour, partially conforming to the Western blotting results. 
4.3.4 Bcl-2 antagonist of cell death (Bad) phosphorylation at S99 
 Examination of the phosphorylation of the Bcl-2 antagonist of cell death (Bad) protein at 
S99 was attempted. However, the signal was extremely weak and not reliably quantifiable by 
Western blot, and thus it was not pursued further. 
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Chapter 5: Discussion 
The importance of the autophagy pathway in cells is clear3. In addition to its role in 
regulating cellular homeostasis and mitigating cellular stress, we now know that autophagy plays 
an important role in cell death22. Our lab aims to elucidate the molecular mechanisms of monocytic 
cell death in response to cytokines such as IFNγ and IL-10, and more recently in response to an 
antimicrobial and autophagic cell death-inducing peptide30. 
 
5.1 U937 monocytic cells are an appropriate model for investigating cell death by kinome 
analysis 
Using a flow cytometric approach, we examined U937 and primary human monocyte cell 
death in response to the Atg peptide. Both U937 and primary monocytes undergo Atg peptide-
induced cell death, similar to what has been reported for other cell types28. This observation, along 
with the cell line’s steady growth rates made it suitable for experiments that require large numbers 
of cells such as kinome analysis. However, given that it is an immortalized cell line with 
chromosomal abnormalities, it is quite possible that there would be significant differences in 
signalling response to the Atg peptide and other stimuli between U937 cells and primary 
monocytes. Therefore, if possible it would be ideal to pursue kinome analysis in primary human 
monocytes, which would be more physiologically relevant.  
 
5.2 Kinome analysis identified multiple potential autophagic cell death signalling pathways 
An autophagy and cell death pathway centric kinome array was successfully designed and 
tested in U937 monocytic cells to gain insight into the phosphorylation cascade that occurs as these 
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cells undergo autophagic cell death in response to the Atg peptide. This array will likely prove 
useful in similar investigations of other autophagic cell death stimuli and cell types in the future. 
Indeed, the kinome analysis revealed several potential pathways leading to autophagic cell death 
in monocytes, as discussed below.  
 
5.2.1 The tumour suppressor protein p53 may be involved 
The tumour suppressor protein p53 is involved in the cellular survival response, often in the 
case of repairing DNA damage. Several key regulatory phosphorylations on this protein were 
present on our array. Using kinome analysis, we visualized an increase in p53 S9 phosphorylation 
at both 15 minutes and 1 hour. Phosphorylation of p53 at S9 may have a role in p53-mediated 
apoptosis via activation of its transcriptional regulation properties50. p53 can also play both a 
positive or inhibitory role in the regulation of autophagy via both transcription-dependent and 
transcription-independent mechanisms51. Thus, I would hypothesize that S9 phosphorylation, as 
visualized by both kinome analysis and Western blotting, appears to play a positive role in Atg 
peptide-induced cell death, and presents an enticing target for further studies. 
 
5.2.2 The transcription factor 4E-BP1 may be involved in autophagy-related cell death 
 4E-BP1 is a repressor of translation initiation that binds to the eIF4E factor and prevents 
its ability to initiate protein synthesis52. A previous study found that 4E-BP1 was capable of being 
phosphorylated at S65, and this phosphorylation was associated with protection against high-dose 
rapamycin-induced cell death53. Rapamycin is a potent inducer of autophagy, and thus the cell 
death occurring in this study may be similar to Atg peptide-induced cell death that we have seen. 
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Interestingly, we found that 4E-BP1 S65 phosphorylation was up-regulated at 15 minutes and 
down-regulated at 1 hour by kinome analysis. Since S65 phosphorylation confers protection 
against autophagy-related cell death, I hypothesized that this flux may indicate an initial resistance 
against cell death that is eventually downregulated and the cell succumbs. However, I was unable 
to confirm this phosphorylation trend by Western blot, and as such it would be prudent to further 
examine the role of 4E-BP1 in autophagic cell death using other methods. 
 
5.2.3 An Na+,K+-ATPase involved in autophagic cell death was differentially phosphorylated 
 In a screen of potential inhibitors of autophagy-inducing peptide cell death, a class of 
compounds termed cardiac glycosides was found to be effective28. These molecules work to inhibit 
Na+,K+-ATPases, which suggests a role for these pumps in this novel form of autophagic cell 
death. A protein phosphorylation site on the α1 subunit of Na+,K+-ATPase was included in our 
array, and was found to be down-regulated early on at 15 minutes but up-regulated at 1 hour. Y10 
phosphorylation has been associated with activation of the pump54, and thus this novel result in 
monocytic cells lends support for a role of Na+,K+-ATPase pumps in this form of cell death. 
Na+,K+-ATPase has multiple functions within the cell that can all be potentially linked to the 
regulation of cell death22. The pump controls cellular resting potential, signal transduction, and 
cytoskeleton modifications such as attachment, motility and cell-cell interactions. Which of these 
functions contributes to autosis is yet to be elucidated, and it is likely that there are other important 
factors required in the signalling cascade as well. However, the Western blotting results show an 
increase in total ATP1A1 levels in response to stimulation with the Atg peptide, which may 
provide a mechanically distinct explanation for the increased level of phosphorylation at 1 hr by 
Western blot. Clearly, there is a need for more in-depth studies into this protein’s role.  
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5.2.4 The potential involvement of the Bcl-2 family of autophagic and apoptotic regulators  
 The Bcl-2 family of proteins is involved in the regulation of both autophagy and apoptosis. 
Several proteins of the Bcl-2 family representing both positive and negative regulators of 
autophagy were present on our array. The Bad protein acts as an inhibitor of apoptosis and 
promotes autophagy via competitive disruption of the inhibitory interactions between Beclin 1 and 
one of the anti-apoptotic proteins of the Bcl-2 family55. Phosphorylation of S99 on the Bad protein 
was found to be up-regulated at 15 minutes and down-regulated by 1 hour. Phosphorylation of Bad 
at S99 has previously been shown to promote binding to 14-3-3 proteins, an association which 
down-regulates the apoptotic response and promotes cell survival56. I hypothesized that this 
phosphorylation may occur early in the response to stressors such as the Atg peptide, followed by 
dephosphorylation and an overwhelming cell death response. Similar to 4E-BP1, I was unable to 
confirm or refute this phosphorylation pattern due to an unreliably detectable signal by Western 
blotting, and thus there is a need for further analysis of Bad’s role in autophagic cell death before 
any conclusions may be drawn. 
 
5.2.5 Other notable kinome analysis results 
 There were notable phosphorylations, for example, on caspase 3 and caspase 8, both of 
which are involved in the proto-typical apoptotic cell death response. Caspase 3 phosphorylation 
at S150 was upregulated at 15 minutes, and caspase 8 phosphorylation at Y380 was upregulated 
at both 15 minutes and 1 hour. Interestingly, both of these phosphorylation events have been 
associated with inhibition of their respective activation, thus potentially inhibiting apoptotic 
mechanisms57. Additionally, caspase 6 phosphorylation at S257 was upregulated at 1 hour, and 
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phosphorylation of this residue leads to caspase 6 inhibition and suppression of apoptotic cell 
death58. This lends further support to the caspase-independent nature of autophagic cell death 
which occurs in response to the Atg peptide22. 
 Another interesting phosphorylation event that was found by kinome analysis in response 
to the Atg peptide is the phosphorylation of p62 on residue S403. This phosphorylation was found 
to be upregulated at 15 minutes, and is associated with an increased affinity of this protein for 
polyubiquitinated proteins and stabilization of its cargo for autophagosome entry59. This may 
implicate a form of heightened and/or selective, chaperone-mediated autophagy in autosis, and 
presents an interesting area for further studies. 
 
5.3 Kinome analysis is subject to some limitations 
While kinome analysis is a powerful tool for the examination of molecular responses, and 
while every effort is made to reduce errors, it is also subject to some limitations. For example, we 
now know that the molecular environment of kinase-substrate phosphorylation reactions can be a 
key regulatory measure. Environmental solubility, pH, and physical access to substrate peptides 
are all important aspects to facilitate phosphorylations, as well as other signalling mechanisms. 
For example, Taelman et al. found that Wnt signaling causes sequestration of Glycogen Synthase 
Kinase 3 from the cytosol into multivesicular bodies, separating the kinase from its cytosolic 
substrates60. In another example, phosphorylation of Akt within the activation T-loop causes a 
charge-induced change in conformation that facilitates further substrate binding61. It can be 
difficult, or nearly impossible, to emulate these conditions in the lab, especially as part of an in 
silico, high-throughput experiment such as kinome analysis. Individual peptides on a solid support 
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can be quite different from in vivo cellular conditions. Thus, we must recognize that this data 
represents a starting point, and certainly further analysis of these phenomena is needed.  
Kinome analysis also provides a means for high-throughput experimentation, the results of 
which can then be finely examined and further probed more directly and concretely. We attempted 
to confirm the kinome results using Western blotting techniques, with somewhat mixed results 
(Table 5-1). p53 phosphorylation at S9 appears to be induced by the Atg peptide, similarly to what 
was found by kinome analysis, whereas Y10 phosphorylation of ATP1A1 and S65 
phosphorylation of 4E-BP1 results are not entirely concordant. Given the difference in targets for 
the two assays, namely the capacity of cellular lysates to phosphorylate targets in kinome analysis 
versus the quantity of phosphorylated proteins detected by Western blotting, it is not entirely 
surprising that there were some inconsistencies.  The discrepancies observed emphasize the need 
for further confirmatory approaches, such as genetic alteration of impugned signalling pathways 
or silencing RNAs, which would more directly implicate the given cellular signalling pathway or 
molecule. 
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Table 5-1. A comparison of kinome and Western blotting results 
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Chapter 6: Conclusion 
High-throughput experimentation methods are becoming more and more prominent in many 
scientific domains. The importance of post-translational protein modifications as cell signaling 
events positions the kinome microarray as an important instrument for rapidly screening the 
intricate molecular mechanisms of many cellular functions.  
An in vitro model to study the regulation of programmed cell death in monocytic cells using 
an autophagic cell-death-inducing peptide was successfully developed. Both primary human 
monocytes and cells of the U937 monocytic line reacted similarly to stimulation with Atg peptide. 
I subsequently designed and tested an autophagy-centric kinome microarray, which also contained 
many other cell death-related peptides. Several peptides correlating to proteins of interest were 
found to be differentially phosphorylated between Atg peptide and Control peptide treatments 
using kinome analysis. These included a member of the Bcl-2 cell death family, the p53 tumour 
suppressor protein, and a Na+,K+-ATPase transporter protein, the latter having been found to be 
required for Atg peptide-induced death28. Western blotting with phospho-specific antibodies was 
conducted to confirm kinome array results. Although there was a clear concordance when 
comparing kinome and Western blot results in the case of p53 for example, there were 
discrepancies, as noted above and in Table 5-1. These discrepancies may be explained in part by 
the differing natures of these two assays as well as their differing methods of analysis. Namely, 
kinome microarrays evaluate the capacity of cellular lysates containing kinases and phosphatases 
to modulate the phosphorylation of proteins/peptides of interest, whereas Western blots detect the 
phosphorylation status of these respective protein targets.  
Nevertheless, our autophagy-centric kinome array is a valuable screening tool for cell death 
signalling events. It will serve as a guide for subsequent functional studies aimed at more directly 
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delineating the molecular mechanisms responsible for autophagic cell death in monocytic cells in 
this case, and will surely be applied to other model systems. 
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